nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—LHCGR—renal system—kidney cancer	0.0245	0.291	CbGeAlD
Goserelin—LHCGR—kidney—kidney cancer	0.0237	0.281	CbGeAlD
Goserelin—LHCGR—gonad—kidney cancer	0.022	0.261	CbGeAlD
Goserelin—LHCGR—Ovarian Infertility Genes—SYNE2—kidney cancer	0.0176	0.298	CbGpPWpGaD
Goserelin—GNRHR—gonad—kidney cancer	0.0142	0.168	CbGeAlD
Goserelin—Pentagastrin—BCHE—kidney cancer	0.00547	1	CrCbGaD
Goserelin—LHCGR—Ovarian Infertility Genes—EGR1—kidney cancer	0.00437	0.0741	CbGpPWpGaD
Goserelin—LHCGR—Arf6 signaling events—MET—kidney cancer	0.00265	0.0449	CbGpPWpGaD
Goserelin—LHCGR—Ovarian Infertility Genes—CDKN1B—kidney cancer	0.00193	0.0327	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—OR4C13—kidney cancer	0.00122	0.0207	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—OR4C13—kidney cancer	0.00111	0.0188	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—ITPR2—kidney cancer	0.00101	0.0172	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.000906	0.0154	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—POMC—kidney cancer	0.000863	0.0146	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—ANXA1—kidney cancer	0.000849	0.0144	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.00084	0.0142	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—OR4C13—kidney cancer	0.000817	0.0139	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.000759	0.0129	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—OR4C13—kidney cancer	0.000742	0.0126	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—OR4C13—kidney cancer	0.000655	0.0111	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—ANXA1—kidney cancer	0.000639	0.0108	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.000562	0.00954	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LATS1—kidney cancer	0.000557	0.00945	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKAP13—kidney cancer	0.000507	0.0086	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AMER1—kidney cancer	0.000474	0.00803	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKAP13—kidney cancer	0.00046	0.00781	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—OR4C13—kidney cancer	0.000439	0.00744	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—ITPR2—kidney cancer	0.000431	0.00731	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—ANXA1—kidney cancer	0.000428	0.00726	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000411	0.00698	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GPC3—kidney cancer	0.000397	0.00673	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CER1—kidney cancer	0.000397	0.00673	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—ITPR2—kidney cancer	0.000392	0.00664	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LATS1—kidney cancer	0.000373	0.00633	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—ANXA1—kidney cancer	0.000361	0.00613	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKAP13—kidney cancer	0.000339	0.00576	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SFRP2—kidney cancer	0.000337	0.00573	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—ANXA1—kidney cancer	0.000328	0.00557	CbGpPWpGaD
Goserelin—Hypertension—Paclitaxel—kidney cancer	0.000322	0.000378	CcSEcCtD
Goserelin—Pruritus—Sunitinib—kidney cancer	0.00032	0.000376	CcSEcCtD
Goserelin—Angiopathy—Capecitabine—kidney cancer	0.000319	0.000374	CcSEcCtD
Goserelin—Immune system disorder—Capecitabine—kidney cancer	0.000317	0.000373	CcSEcCtD
Goserelin—Arthralgia—Paclitaxel—kidney cancer	0.000317	0.000373	CcSEcCtD
Goserelin—Chest pain—Paclitaxel—kidney cancer	0.000317	0.000373	CcSEcCtD
Goserelin—Myalgia—Paclitaxel—kidney cancer	0.000317	0.000373	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—AMER1—kidney cancer	0.000317	0.00538	CbGpPWpGaD
Goserelin—Anxiety—Paclitaxel—kidney cancer	0.000316	0.000371	CcSEcCtD
Goserelin—Decreased appetite—Gemcitabine—kidney cancer	0.000316	0.000371	CcSEcCtD
Goserelin—Hypersensitivity—Dactinomycin—kidney cancer	0.000316	0.000371	CcSEcCtD
Goserelin—Chills—Capecitabine—kidney cancer	0.000315	0.00037	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000315	0.00037	CcSEcCtD
Goserelin—Arrhythmia—Capecitabine—kidney cancer	0.000314	0.000369	CcSEcCtD
Goserelin—Discomfort—Paclitaxel—kidney cancer	0.000313	0.000368	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—POMC—kidney cancer	0.000313	0.00531	CbGpPWpGaD
Goserelin—Fatigue—Gemcitabine—kidney cancer	0.000313	0.000368	CcSEcCtD
Goserelin—Gastrointestinal pain—Vincristine—kidney cancer	0.000313	0.000368	CcSEcCtD
Goserelin—Dizziness—Sorafenib—kidney cancer	0.000311	0.000366	CcSEcCtD
Goserelin—Pain—Gemcitabine—kidney cancer	0.000311	0.000365	CcSEcCtD
Goserelin—Constipation—Gemcitabine—kidney cancer	0.000311	0.000365	CcSEcCtD
Goserelin—Nausea—Erlotinib—kidney cancer	0.000311	0.000365	CcSEcCtD
Goserelin—Alopecia—Capecitabine—kidney cancer	0.00031	0.000365	CcSEcCtD
Goserelin—Dry mouth—Paclitaxel—kidney cancer	0.00031	0.000365	CcSEcCtD
Goserelin—Mood swings—Doxorubicin—kidney cancer	0.00031	0.000364	CcSEcCtD
Goserelin—Diarrhoea—Sunitinib—kidney cancer	0.00031	0.000364	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—AKAP13—kidney cancer	0.000308	0.00523	CbGpPWpGaD
Goserelin—Mental disorder—Capecitabine—kidney cancer	0.000308	0.000362	CcSEcCtD
Goserelin—Asthenia—Dactinomycin—kidney cancer	0.000308	0.000361	CcSEcCtD
Goserelin—Confusional state—Paclitaxel—kidney cancer	0.000307	0.00036	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	0.000307	0.0052	CbGpPWpGaD
Goserelin—Erythema—Capecitabine—kidney cancer	0.000306	0.000359	CcSEcCtD
Goserelin—Malnutrition—Capecitabine—kidney cancer	0.000306	0.000359	CcSEcCtD
Goserelin—Oedema—Paclitaxel—kidney cancer	0.000304	0.000357	CcSEcCtD
Goserelin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000304	0.000357	CcSEcCtD
Goserelin—Abdominal pain—Vincristine—kidney cancer	0.000303	0.000356	CcSEcCtD
Goserelin—Body temperature increased—Vincristine—kidney cancer	0.000303	0.000356	CcSEcCtD
Goserelin—Infection—Paclitaxel—kidney cancer	0.000302	0.000355	CcSEcCtD
Goserelin—Flatulence—Capecitabine—kidney cancer	0.000301	0.000354	CcSEcCtD
Goserelin—Dry skin—Doxorubicin—kidney cancer	0.0003	0.000352	CcSEcCtD
Goserelin—Dizziness—Sunitinib—kidney cancer	0.000299	0.000352	CcSEcCtD
Goserelin—Feeling abnormal—Gemcitabine—kidney cancer	0.000299	0.000352	CcSEcCtD
Goserelin—Shock—Paclitaxel—kidney cancer	0.000299	0.000352	CcSEcCtD
Goserelin—Vomiting—Sorafenib—kidney cancer	0.000299	0.000351	CcSEcCtD
Goserelin—Nervous system disorder—Paclitaxel—kidney cancer	0.000298	0.00035	CcSEcCtD
Goserelin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000298	0.00035	CcSEcCtD
Goserelin—Tachycardia—Paclitaxel—kidney cancer	0.000297	0.000349	CcSEcCtD
Goserelin—Rash—Sorafenib—kidney cancer	0.000297	0.000348	CcSEcCtD
Goserelin—Dermatitis—Sorafenib—kidney cancer	0.000296	0.000348	CcSEcCtD
Goserelin—Back pain—Capecitabine—kidney cancer	0.000296	0.000348	CcSEcCtD
Goserelin—Breast disorder—Doxorubicin—kidney cancer	0.000296	0.000348	CcSEcCtD
Goserelin—Skin disorder—Paclitaxel—kidney cancer	0.000295	0.000347	CcSEcCtD
Goserelin—Headache—Sorafenib—kidney cancer	0.000295	0.000346	CcSEcCtD
Goserelin—Muscle spasms—Capecitabine—kidney cancer	0.000294	0.000345	CcSEcCtD
Goserelin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000294	0.000345	CcSEcCtD
Goserelin—Diarrhoea—Dactinomycin—kidney cancer	0.000293	0.000344	CcSEcCtD
Goserelin—Anorexia—Paclitaxel—kidney cancer	0.00029	0.000341	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—ITPR2—kidney cancer	0.000289	0.0049	CbGpPWpGaD
Goserelin—Vision blurred—Capecitabine—kidney cancer	0.000288	0.000339	CcSEcCtD
Goserelin—Vomiting—Sunitinib—kidney cancer	0.000288	0.000338	CcSEcCtD
Goserelin—Body temperature increased—Gemcitabine—kidney cancer	0.000287	0.000337	CcSEcCtD
Goserelin—Rash—Sunitinib—kidney cancer	0.000285	0.000335	CcSEcCtD
Goserelin—Dermatitis—Sunitinib—kidney cancer	0.000285	0.000335	CcSEcCtD
Goserelin—Hypotension—Paclitaxel—kidney cancer	0.000284	0.000334	CcSEcCtD
Goserelin—Ill-defined disorder—Capecitabine—kidney cancer	0.000284	0.000333	CcSEcCtD
Goserelin—Headache—Sunitinib—kidney cancer	0.000284	0.000333	CcSEcCtD
Goserelin—Influenza—Doxorubicin—kidney cancer	0.000283	0.000332	CcSEcCtD
Goserelin—Anaemia—Capecitabine—kidney cancer	0.000283	0.000332	CcSEcCtD
Goserelin—Hypersensitivity—Vincristine—kidney cancer	0.000282	0.000331	CcSEcCtD
Goserelin—Nausea—Sorafenib—kidney cancer	0.000279	0.000328	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000277	0.000326	CcSEcCtD
Goserelin—Malaise—Capecitabine—kidney cancer	0.000276	0.000324	CcSEcCtD
Goserelin—Angina pectoris—Doxorubicin—kidney cancer	0.000276	0.000324	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000275	0.00467	CbGpPWpGaD
Goserelin—Insomnia—Paclitaxel—kidney cancer	0.000275	0.000323	CcSEcCtD
Goserelin—Asthenia—Vincristine—kidney cancer	0.000275	0.000323	CcSEcCtD
Goserelin—Leukopenia—Capecitabine—kidney cancer	0.000274	0.000322	CcSEcCtD
Goserelin—Paraesthesia—Paclitaxel—kidney cancer	0.000273	0.000321	CcSEcCtD
Goserelin—Vomiting—Dactinomycin—kidney cancer	0.000273	0.00032	CcSEcCtD
Goserelin—Bronchitis—Doxorubicin—kidney cancer	0.000272	0.00032	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—AKAP13—kidney cancer	0.000272	0.00461	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CASP2—kidney cancer	0.000272	0.00461	CbGpPWpGaD
Goserelin—Dyspnoea—Paclitaxel—kidney cancer	0.000271	0.000319	CcSEcCtD
Goserelin—Somnolence—Paclitaxel—kidney cancer	0.00027	0.000318	CcSEcCtD
Goserelin—Palpitations—Capecitabine—kidney cancer	0.00027	0.000317	CcSEcCtD
Goserelin—Rash—Dactinomycin—kidney cancer	0.00027	0.000317	CcSEcCtD
Goserelin—Nausea—Sunitinib—kidney cancer	0.000269	0.000316	CcSEcCtD
Goserelin—Dyspepsia—Paclitaxel—kidney cancer	0.000268	0.000315	CcSEcCtD
Goserelin—Cough—Capecitabine—kidney cancer	0.000267	0.000314	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GPC3—kidney cancer	0.000266	0.00451	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CER1—kidney cancer	0.000266	0.00451	CbGpPWpGaD
Goserelin—Dysuria—Doxorubicin—kidney cancer	0.000265	0.000311	CcSEcCtD
Goserelin—Decreased appetite—Paclitaxel—kidney cancer	0.000264	0.000311	CcSEcCtD
Goserelin—Hypertension—Capecitabine—kidney cancer	0.000264	0.00031	CcSEcCtD
Goserelin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000263	0.000309	CcSEcCtD
Goserelin—Fatigue—Paclitaxel—kidney cancer	0.000262	0.000308	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ITPR2—kidney cancer	0.000262	0.00445	CbGpPWpGaD
Goserelin—Diarrhoea—Vincristine—kidney cancer	0.000262	0.000308	CcSEcCtD
Goserelin—Pollakiuria—Doxorubicin—kidney cancer	0.000261	0.000307	CcSEcCtD
Goserelin—Asthenia—Gemcitabine—kidney cancer	0.000261	0.000306	CcSEcCtD
Goserelin—Chest pain—Capecitabine—kidney cancer	0.00026	0.000306	CcSEcCtD
Goserelin—Arthralgia—Capecitabine—kidney cancer	0.00026	0.000306	CcSEcCtD
Goserelin—Myalgia—Capecitabine—kidney cancer	0.00026	0.000306	CcSEcCtD
Goserelin—Pain—Paclitaxel—kidney cancer	0.00026	0.000306	CcSEcCtD
Goserelin—Constipation—Paclitaxel—kidney cancer	0.00026	0.000306	CcSEcCtD
Goserelin—Anxiety—Capecitabine—kidney cancer	0.000259	0.000305	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000259	0.000304	CcSEcCtD
Goserelin—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000258	0.000303	CcSEcCtD
Goserelin—Weight increased—Doxorubicin—kidney cancer	0.000257	0.000302	CcSEcCtD
Goserelin—Discomfort—Capecitabine—kidney cancer	0.000257	0.000302	CcSEcCtD
Goserelin—Pruritus—Gemcitabine—kidney cancer	0.000257	0.000302	CcSEcCtD
Goserelin—Hyperglycaemia—Doxorubicin—kidney cancer	0.000255	0.0003	CcSEcCtD
Goserelin—Dry mouth—Capecitabine—kidney cancer	0.000255	0.000299	CcSEcCtD
Goserelin—Nausea—Dactinomycin—kidney cancer	0.000255	0.000299	CcSEcCtD
Goserelin—Pneumonia—Doxorubicin—kidney cancer	0.000254	0.000298	CcSEcCtD
Goserelin—Dizziness—Vincristine—kidney cancer	0.000253	0.000297	CcSEcCtD
Goserelin—Drowsiness—Doxorubicin—kidney cancer	0.000252	0.000296	CcSEcCtD
Goserelin—Confusional state—Capecitabine—kidney cancer	0.000252	0.000296	CcSEcCtD
Goserelin—Feeling abnormal—Paclitaxel—kidney cancer	0.000251	0.000294	CcSEcCtD
Goserelin—Oedema—Capecitabine—kidney cancer	0.00025	0.000293	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—GRB7—kidney cancer	0.000249	0.00422	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000249	0.000292	CcSEcCtD
Goserelin—Diarrhoea—Gemcitabine—kidney cancer	0.000249	0.000292	CcSEcCtD
Goserelin—Renal failure—Doxorubicin—kidney cancer	0.000248	0.000291	CcSEcCtD
Goserelin—Infection—Capecitabine—kidney cancer	0.000248	0.000291	CcSEcCtD
Goserelin—Jaundice—Doxorubicin—kidney cancer	0.000246	0.000289	CcSEcCtD
Goserelin—Shock—Capecitabine—kidney cancer	0.000246	0.000288	CcSEcCtD
Goserelin—Urinary tract infection—Doxorubicin—kidney cancer	0.000245	0.000288	CcSEcCtD
Goserelin—Nervous system disorder—Capecitabine—kidney cancer	0.000245	0.000288	CcSEcCtD
Goserelin—Thrombocytopenia—Capecitabine—kidney cancer	0.000244	0.000287	CcSEcCtD
Goserelin—Tachycardia—Capecitabine—kidney cancer	0.000244	0.000286	CcSEcCtD
Goserelin—Vomiting—Vincristine—kidney cancer	0.000243	0.000286	CcSEcCtD
Goserelin—Skin disorder—Capecitabine—kidney cancer	0.000242	0.000285	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—ANXA1—kidney cancer	0.000242	0.0041	CbGpPWpGaD
Goserelin—Sweating—Doxorubicin—kidney cancer	0.000242	0.000284	CcSEcCtD
Goserelin—Urticaria—Paclitaxel—kidney cancer	0.000242	0.000284	CcSEcCtD
Goserelin—Rash—Vincristine—kidney cancer	0.000241	0.000284	CcSEcCtD
Goserelin—Hyperhidrosis—Capecitabine—kidney cancer	0.000241	0.000283	CcSEcCtD
Goserelin—Dermatitis—Vincristine—kidney cancer	0.000241	0.000283	CcSEcCtD
Goserelin—Haematuria—Doxorubicin—kidney cancer	0.000241	0.000283	CcSEcCtD
Goserelin—Abdominal pain—Paclitaxel—kidney cancer	0.00024	0.000282	CcSEcCtD
Goserelin—Body temperature increased—Paclitaxel—kidney cancer	0.00024	0.000282	CcSEcCtD
Goserelin—Headache—Vincristine—kidney cancer	0.00024	0.000282	CcSEcCtD
Goserelin—Epistaxis—Doxorubicin—kidney cancer	0.000238	0.00028	CcSEcCtD
Goserelin—Anorexia—Capecitabine—kidney cancer	0.000238	0.000279	CcSEcCtD
Goserelin—Sinusitis—Doxorubicin—kidney cancer	0.000237	0.000278	CcSEcCtD
Goserelin—Hypotension—Capecitabine—kidney cancer	0.000233	0.000274	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ITPR2—kidney cancer	0.000231	0.00392	CbGpPWpGaD
Goserelin—Vomiting—Gemcitabine—kidney cancer	0.000231	0.000271	CcSEcCtD
Goserelin—Rash—Gemcitabine—kidney cancer	0.000229	0.000269	CcSEcCtD
Goserelin—Dermatitis—Gemcitabine—kidney cancer	0.000229	0.000269	CcSEcCtD
Goserelin—Haemoglobin—Doxorubicin—kidney cancer	0.000228	0.000267	CcSEcCtD
Goserelin—Headache—Gemcitabine—kidney cancer	0.000228	0.000267	CcSEcCtD
Goserelin—Nausea—Vincristine—kidney cancer	0.000227	0.000267	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000227	0.000267	CcSEcCtD
Goserelin—Rhinitis—Doxorubicin—kidney cancer	0.000227	0.000267	CcSEcCtD
Goserelin—Hepatitis—Doxorubicin—kidney cancer	0.000226	0.000266	CcSEcCtD
Goserelin—Haemorrhage—Doxorubicin—kidney cancer	0.000226	0.000266	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—SFRP2—kidney cancer	0.000226	0.00383	CbGpPWpGaD
Goserelin—Insomnia—Capecitabine—kidney cancer	0.000226	0.000265	CcSEcCtD
Goserelin—Pharyngitis—Doxorubicin—kidney cancer	0.000225	0.000264	CcSEcCtD
Goserelin—Paraesthesia—Capecitabine—kidney cancer	0.000224	0.000263	CcSEcCtD
Goserelin—Hypersensitivity—Paclitaxel—kidney cancer	0.000224	0.000263	CcSEcCtD
Goserelin—Urinary tract disorder—Doxorubicin—kidney cancer	0.000224	0.000263	CcSEcCtD
Goserelin—Oedema peripheral—Doxorubicin—kidney cancer	0.000223	0.000262	CcSEcCtD
Goserelin—Dyspnoea—Capecitabine—kidney cancer	0.000223	0.000261	CcSEcCtD
Goserelin—Urethral disorder—Doxorubicin—kidney cancer	0.000222	0.000261	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000221	0.00375	CbGpPWpGaD
Goserelin—Dyspepsia—Capecitabine—kidney cancer	0.00022	0.000258	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ANXA1—kidney cancer	0.00022	0.00373	CbGpPWpGaD
Goserelin—Asthenia—Paclitaxel—kidney cancer	0.000218	0.000256	CcSEcCtD
Goserelin—Decreased appetite—Capecitabine—kidney cancer	0.000217	0.000255	CcSEcCtD
Goserelin—Nausea—Gemcitabine—kidney cancer	0.000216	0.000253	CcSEcCtD
Goserelin—Fatigue—Capecitabine—kidney cancer	0.000215	0.000253	CcSEcCtD
Goserelin—Pruritus—Paclitaxel—kidney cancer	0.000215	0.000253	CcSEcCtD
Goserelin—Pain—Capecitabine—kidney cancer	0.000213	0.000251	CcSEcCtD
Goserelin—Constipation—Capecitabine—kidney cancer	0.000213	0.000251	CcSEcCtD
Goserelin—Eye disorder—Doxorubicin—kidney cancer	0.000212	0.000249	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.00021	0.00357	CbGpPWpGaD
Goserelin—Cardiac disorder—Doxorubicin—kidney cancer	0.00021	0.000247	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CTNNA1—kidney cancer	0.00021	0.00356	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—POMC—kidney cancer	0.00021	0.00356	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EIF4EBP1—kidney cancer	0.000208	0.00354	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HSPB1—kidney cancer	0.000208	0.00354	CbGpPWpGaD
Goserelin—Diarrhoea—Paclitaxel—kidney cancer	0.000208	0.000244	CcSEcCtD
Goserelin—Feeling abnormal—Capecitabine—kidney cancer	0.000206	0.000242	CcSEcCtD
Goserelin—Angiopathy—Doxorubicin—kidney cancer	0.000205	0.000241	CcSEcCtD
Goserelin—Immune system disorder—Doxorubicin—kidney cancer	0.000205	0.00024	CcSEcCtD
Goserelin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000204	0.00024	CcSEcCtD
Goserelin—GNRHR—G alpha (q) signalling events—PIK3CA—kidney cancer	0.000204	0.00346	CbGpPWpGaD
Goserelin—Chills—Doxorubicin—kidney cancer	0.000203	0.000239	CcSEcCtD
Goserelin—Arrhythmia—Doxorubicin—kidney cancer	0.000202	0.000238	CcSEcCtD
Goserelin—Dizziness—Paclitaxel—kidney cancer	0.000201	0.000236	CcSEcCtD
Goserelin—Alopecia—Doxorubicin—kidney cancer	0.0002	0.000235	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000199	0.00337	CbGpPWpGaD
Goserelin—Mental disorder—Doxorubicin—kidney cancer	0.000198	0.000233	CcSEcCtD
Goserelin—Urticaria—Capecitabine—kidney cancer	0.000198	0.000233	CcSEcCtD
Goserelin—Body temperature increased—Capecitabine—kidney cancer	0.000197	0.000232	CcSEcCtD
Goserelin—Abdominal pain—Capecitabine—kidney cancer	0.000197	0.000232	CcSEcCtD
Goserelin—Malnutrition—Doxorubicin—kidney cancer	0.000197	0.000232	CcSEcCtD
Goserelin—Erythema—Doxorubicin—kidney cancer	0.000197	0.000232	CcSEcCtD
Goserelin—Flatulence—Doxorubicin—kidney cancer	0.000194	0.000228	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—TSC1—kidney cancer	0.000194	0.00329	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ANXA1—kidney cancer	0.000194	0.00329	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PSMD7—kidney cancer	0.000194	0.00329	CbGpPWpGaD
Goserelin—Tension—Doxorubicin—kidney cancer	0.000193	0.000227	CcSEcCtD
Goserelin—Vomiting—Paclitaxel—kidney cancer	0.000193	0.000227	CcSEcCtD
Goserelin—Rash—Paclitaxel—kidney cancer	0.000192	0.000225	CcSEcCtD
Goserelin—Dermatitis—Paclitaxel—kidney cancer	0.000192	0.000225	CcSEcCtD
Goserelin—Nervousness—Doxorubicin—kidney cancer	0.000191	0.000225	CcSEcCtD
Goserelin—Back pain—Doxorubicin—kidney cancer	0.000191	0.000224	CcSEcCtD
Goserelin—Headache—Paclitaxel—kidney cancer	0.000191	0.000224	CcSEcCtD
Goserelin—Muscle spasms—Doxorubicin—kidney cancer	0.00019	0.000223	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—FLT1—kidney cancer	0.000188	0.00318	CbGpPWpGaD
Goserelin—Vision blurred—Doxorubicin—kidney cancer	0.000186	0.000218	CcSEcCtD
Goserelin—Hypersensitivity—Capecitabine—kidney cancer	0.000184	0.000216	CcSEcCtD
Goserelin—Ill-defined disorder—Doxorubicin—kidney cancer	0.000183	0.000215	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000182	0.0031	CbGpPWpGaD
Goserelin—Anaemia—Doxorubicin—kidney cancer	0.000182	0.000214	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—AKAP13—kidney cancer	0.000182	0.00309	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CASP2—kidney cancer	0.000182	0.00309	CbGpPWpGaD
Goserelin—Nausea—Paclitaxel—kidney cancer	0.000181	0.000212	CcSEcCtD
Goserelin—Asthenia—Capecitabine—kidney cancer	0.000179	0.00021	CcSEcCtD
Goserelin—Malaise—Doxorubicin—kidney cancer	0.000178	0.000209	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—POMC—kidney cancer	0.000177	0.003	CbGpPWpGaD
Goserelin—Pruritus—Capecitabine—kidney cancer	0.000177	0.000207	CcSEcCtD
Goserelin—Leukopenia—Doxorubicin—kidney cancer	0.000176	0.000207	CcSEcCtD
Goserelin—Palpitations—Doxorubicin—kidney cancer	0.000174	0.000205	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—JUNB—kidney cancer	0.000174	0.00295	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PAK1—kidney cancer	0.000174	0.00295	CbGpPWpGaD
Goserelin—Cough—Doxorubicin—kidney cancer	0.000172	0.000202	CcSEcCtD
Goserelin—Convulsion—Doxorubicin—kidney cancer	0.000171	0.000201	CcSEcCtD
Goserelin—Diarrhoea—Capecitabine—kidney cancer	0.000171	0.000201	CcSEcCtD
Goserelin—Hypertension—Doxorubicin—kidney cancer	0.00017	0.0002	CcSEcCtD
Goserelin—Myalgia—Doxorubicin—kidney cancer	0.000168	0.000197	CcSEcCtD
Goserelin—Chest pain—Doxorubicin—kidney cancer	0.000168	0.000197	CcSEcCtD
Goserelin—Arthralgia—Doxorubicin—kidney cancer	0.000168	0.000197	CcSEcCtD
Goserelin—Anxiety—Doxorubicin—kidney cancer	0.000167	0.000196	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000167	0.000196	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GRB7—kidney cancer	0.000167	0.00283	CbGpPWpGaD
Goserelin—Discomfort—Doxorubicin—kidney cancer	0.000166	0.000195	CcSEcCtD
Goserelin—Dizziness—Capecitabine—kidney cancer	0.000165	0.000194	CcSEcCtD
Goserelin—Dry mouth—Doxorubicin—kidney cancer	0.000164	0.000193	CcSEcCtD
Goserelin—Confusional state—Doxorubicin—kidney cancer	0.000162	0.000191	CcSEcCtD
Goserelin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000161	0.000189	CcSEcCtD
Goserelin—Oedema—Doxorubicin—kidney cancer	0.000161	0.000189	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—POMC—kidney cancer	0.000161	0.00273	CbGpPWpGaD
Goserelin—Infection—Doxorubicin—kidney cancer	0.00016	0.000188	CcSEcCtD
Goserelin—Vomiting—Capecitabine—kidney cancer	0.000159	0.000186	CcSEcCtD
Goserelin—Shock—Doxorubicin—kidney cancer	0.000158	0.000186	CcSEcCtD
Goserelin—Nervous system disorder—Doxorubicin—kidney cancer	0.000158	0.000185	CcSEcCtD
Goserelin—Thrombocytopenia—Doxorubicin—kidney cancer	0.000158	0.000185	CcSEcCtD
Goserelin—Rash—Capecitabine—kidney cancer	0.000157	0.000185	CcSEcCtD
Goserelin—Dermatitis—Capecitabine—kidney cancer	0.000157	0.000185	CcSEcCtD
Goserelin—Tachycardia—Doxorubicin—kidney cancer	0.000157	0.000184	CcSEcCtD
Goserelin—Headache—Capecitabine—kidney cancer	0.000156	0.000184	CcSEcCtD
Goserelin—Skin disorder—Doxorubicin—kidney cancer	0.000156	0.000184	CcSEcCtD
Goserelin—Hyperhidrosis—Doxorubicin—kidney cancer	0.000156	0.000183	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ITPR2—kidney cancer	0.000155	0.00263	CbGpPWpGaD
Goserelin—Anorexia—Doxorubicin—kidney cancer	0.000153	0.00018	CcSEcCtD
Goserelin—Hypotension—Doxorubicin—kidney cancer	0.00015	0.000177	CcSEcCtD
Goserelin—Nausea—Capecitabine—kidney cancer	0.000148	0.000174	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000147	0.000172	CcSEcCtD
Goserelin—Insomnia—Doxorubicin—kidney cancer	0.000146	0.000171	CcSEcCtD
Goserelin—Paraesthesia—Doxorubicin—kidney cancer	0.000144	0.00017	CcSEcCtD
Goserelin—Dyspnoea—Doxorubicin—kidney cancer	0.000143	0.000169	CcSEcCtD
Goserelin—Somnolence—Doxorubicin—kidney cancer	0.000143	0.000168	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IGF2—kidney cancer	0.000142	0.00241	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CDKN2B—kidney cancer	0.000142	0.0024	CbGpPWpGaD
Goserelin—Dyspepsia—Doxorubicin—kidney cancer	0.000142	0.000166	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CTNNA1—kidney cancer	0.00014	0.00238	CbGpPWpGaD
Goserelin—Decreased appetite—Doxorubicin—kidney cancer	0.00014	0.000164	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HSPB1—kidney cancer	0.00014	0.00237	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EIF4EBP1—kidney cancer	0.00014	0.00237	CbGpPWpGaD
Goserelin—Fatigue—Doxorubicin—kidney cancer	0.000139	0.000163	CcSEcCtD
Goserelin—Constipation—Doxorubicin—kidney cancer	0.000138	0.000162	CcSEcCtD
Goserelin—Pain—Doxorubicin—kidney cancer	0.000138	0.000162	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IGF1R—kidney cancer	0.000138	0.00233	CbGpPWpGaD
Goserelin—Feeling abnormal—Doxorubicin—kidney cancer	0.000133	0.000156	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—RAF1—kidney cancer	0.000133	0.00225	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000132	0.000155	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—IL2—kidney cancer	0.000131	0.00222	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PSMD7—kidney cancer	0.00013	0.0022	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ANXA1—kidney cancer	0.00013	0.0022	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TSC1—kidney cancer	0.00013	0.0022	CbGpPWpGaD
Goserelin—Urticaria—Doxorubicin—kidney cancer	0.000128	0.00015	CcSEcCtD
Goserelin—Abdominal pain—Doxorubicin—kidney cancer	0.000127	0.000149	CcSEcCtD
Goserelin—Body temperature increased—Doxorubicin—kidney cancer	0.000127	0.000149	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—FLT1—kidney cancer	0.000126	0.00213	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL2—kidney cancer	0.000119	0.00202	CbGpPWpGaD
Goserelin—Hypersensitivity—Doxorubicin—kidney cancer	0.000119	0.000139	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—POMC—kidney cancer	0.000118	0.00201	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PAK1—kidney cancer	0.000116	0.00198	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—JUNB—kidney cancer	0.000116	0.00198	CbGpPWpGaD
Goserelin—Asthenia—Doxorubicin—kidney cancer	0.000115	0.000136	CcSEcCtD
Goserelin—Pruritus—Doxorubicin—kidney cancer	0.000114	0.000134	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HIF1A—kidney cancer	0.000113	0.00192	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TSC2—kidney cancer	0.000113	0.00192	CbGpPWpGaD
Goserelin—Diarrhoea—Doxorubicin—kidney cancer	0.00011	0.000129	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—KDR—kidney cancer	0.000108	0.00184	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—POMC—kidney cancer	0.000108	0.00183	CbGpPWpGaD
Goserelin—Dizziness—Doxorubicin—kidney cancer	0.000106	0.000125	CcSEcCtD
Goserelin—Vomiting—Doxorubicin—kidney cancer	0.000102	0.00012	CcSEcCtD
Goserelin—Rash—Doxorubicin—kidney cancer	0.000101	0.000119	CcSEcCtD
Goserelin—Dermatitis—Doxorubicin—kidney cancer	0.000101	0.000119	CcSEcCtD
Goserelin—Headache—Doxorubicin—kidney cancer	0.000101	0.000118	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—KIT—kidney cancer	9.98e-05	0.00169	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APC—kidney cancer	9.98e-05	0.00169	CbGpPWpGaD
Goserelin—Nausea—Doxorubicin—kidney cancer	9.56e-05	0.000112	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—MAPK3—kidney cancer	9.55e-05	0.00162	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF2—kidney cancer	9.52e-05	0.00162	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—POMC—kidney cancer	9.5e-05	0.00161	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDKN2B—kidney cancer	9.48e-05	0.00161	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—BRAF—kidney cancer	9.38e-05	0.00159	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF1R—kidney cancer	9.21e-05	0.00156	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MAPK1—kidney cancer	9.09e-05	0.00154	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—RAF1—kidney cancer	8.87e-05	0.00151	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—IL2—kidney cancer	8.76e-05	0.00149	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CA—kidney cancer	8.69e-05	0.00147	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—KRAS—kidney cancer	8.59e-05	0.00146	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL2—kidney cancer	7.95e-05	0.00135	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CA—kidney cancer	7.89e-05	0.00134	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RAF1—kidney cancer	7.83e-05	0.00133	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RELA—kidney cancer	7.79e-05	0.00132	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ERBB2—kidney cancer	7.75e-05	0.00131	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MTOR—kidney cancer	7.64e-05	0.0013	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HIF1A—kidney cancer	7.58e-05	0.00129	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TSC2—kidney cancer	7.56e-05	0.00128	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KDR—kidney cancer	7.25e-05	0.00123	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CDKN1B—kidney cancer	7.17e-05	0.00122	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL2—kidney cancer	7.02e-05	0.00119	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCND1—kidney cancer	6.84e-05	0.00116	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—JUN—kidney cancer	6.83e-05	0.00116	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CTNNB1—kidney cancer	6.78e-05	0.00115	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KIT—kidney cancer	6.68e-05	0.00113	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APC—kidney cancer	6.68e-05	0.00113	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTEN—kidney cancer	6.6e-05	0.00112	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MAPK3—kidney cancer	6.4e-05	0.00109	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—POMC—kidney cancer	6.36e-05	0.00108	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BRAF—kidney cancer	6.28e-05	0.00106	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MAPK1—kidney cancer	6.09e-05	0.00103	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—kidney cancer	5.97e-05	0.00101	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CA—kidney cancer	5.81e-05	0.000987	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—KRAS—kidney cancer	5.75e-05	0.000975	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK3—kidney cancer	5.64e-05	0.000957	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MYC—kidney cancer	5.49e-05	0.000931	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK1—kidney cancer	5.37e-05	0.000911	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CA—kidney cancer	5.28e-05	0.000896	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RAF1—kidney cancer	5.24e-05	0.000889	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RELA—kidney cancer	5.22e-05	0.000885	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ERBB2—kidney cancer	5.19e-05	0.00088	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MTOR—kidney cancer	5.12e-05	0.000868	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KRAS—kidney cancer	5.07e-05	0.00086	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDKN1B—kidney cancer	4.8e-05	0.000815	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL2—kidney cancer	4.7e-05	0.000797	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CA—kidney cancer	4.66e-05	0.000791	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCND1—kidney cancer	4.58e-05	0.000777	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—JUN—kidney cancer	4.57e-05	0.000776	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CTNNB1—kidney cancer	4.54e-05	0.00077	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TP53—kidney cancer	4.51e-05	0.000765	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTEN—kidney cancer	4.42e-05	0.00075	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—kidney cancer	3.99e-05	0.000678	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK3—kidney cancer	3.78e-05	0.000641	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MYC—kidney cancer	3.67e-05	0.000623	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK1—kidney cancer	3.59e-05	0.00061	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KRAS—kidney cancer	3.4e-05	0.000576	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CA—kidney cancer	3.12e-05	0.000529	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TP53—kidney cancer	3.02e-05	0.000512	CbGpPWpGaD
